High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
17.26B
+4.85%
3.309
+5.73%
17.02B
+3.75%
2.979
+6.77%
18.31B
+3.5%
3.713
+3.43%
Estimates Revision
The market is revising Downward the revenue expectations for Accenture plc (ACN) for FY2025, with the revenue forecasts being adjusted by -0.23% over the past three months. During the same period, the stock price has changed by -22.46%.
Revenue Estimates for FY2025
Revise Downward
-0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.19%
In Past 3 Month
Stock Price
Go Down
-22.46%
In Past 3 Month
19 Analyst Rating
0Wall Street analysts forecast ACN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACN is 361.33 USD with a low forecast of 280.00 USD and a high forecast of 415.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
5 Hold
0 Sell
Moderate Buy
0Current: 293.390
Low
280.00
Averages
361.33
High
415.00
0Current: 293.390
Low
280.00
Averages
361.33
High
415.00
Piper Sandler
Arvind Ramnani
Buy
Maintains
$364 → $355
2025-04-16
Reason
Piper Sandler
Arvind Ramnani
Price Target
$364 → $355
2025-04-16
Maintains
Buy
Reason
Piper Sandler lowered the firm's price target on Accenture to $355 from $364 and keeps an Overweight rating on the shares. The firm cut estimates across its IT services coverage. Piepr believes the Q1 results will likely be in-line, but sees greater risk for second half numbers. With shifting tariff policies, the recent 90-day extension and ongoing trade war with China, Piper expects enterprise tech spend to be less favorable than anticipated, and decision making for new project starts to slow, the analyst tells investors in a research note.
Barclays
Ramsey El-Assal
Buy
Maintains
$415 → $390
2025-03-24
Reason
Barclays
Ramsey El-Assal
Price Target
$415 → $390
2025-03-24
Maintains
Buy
Reason
Barclays reiterated an Overweight rating and $415 price target on Accenture after the company reported a slight Q2 top/bottom-line beat and raised the midpoint of its FY25 guidance, despite a volatile political and economic environment. The firm said the stock has overcorrected on DOGE fears, and that it would be a buyer on the weakness. Barclays added that while it views a portion off Accenture Federal Services work as at-risk, it has yet to see large-scale cancellations, and that the downward move in recent weeks is overdone.
Baird
David Koning
Buy
Maintains
$390 → $372
2025-03-21
Reason
Baird
David Koning
Price Target
$390 → $372
2025-03-21
Maintains
Buy
Reason
Baird upgraded Accenture to Outperform from Neutral with an unchanged price target of $390. The firm says the stock has been weak the past few years on "sluggish" IT demand and more recently Department of Government Efficiency fears as U.S. federal spend was 8% of Accenture's fiscal 2024 revenue. The analyst expects the company's fiscal Q2 to beat estimates "mildly" and views its Managed Services demand to be strong, which is 50% of revenue. Accenture can return to favor given its "strong moat," free cash flow and accelerating growth, and can ultimately benefit from generative artificial intelligence demand, the analyst tells investors in a research note.
Guggenheim
Jonathan Lee
Strong Buy
Maintains
$400 → $395
2025-03-21
Reason
Guggenheim
Jonathan Lee
Price Target
$400 → $395
2025-03-21
Maintains
Strong Buy
Reason
Guggenheim lowered the firm's price target on Accenture to $395 from $400 and keeps a Buy rating on the shares. Management's protection of the high-end of its FY25 revenue growth outlook despite elevated economic and geopolitical uncertainty, is likely to draw skepticism, the analyst tells investors in a research note. Guggenheim remains constructive on Accenture shares over the medium-term as the firm continues to see the company benefiting from delivering on clients' cost optimization initiatives and aiding in enterprises' transformational agendas.
UBS
Kevin Mcveigh
Strong Buy
Maintains
$455 → $387
2025-03-21
Reason
UBS
Kevin Mcveigh
Price Target
$455 → $387
2025-03-21
Maintains
Strong Buy
Reason
RBC Capital
Daniel Perlin
Buy
Maintains
$399 → $392
2025-03-21
Reason
RBC Capital
Daniel Perlin
Price Target
$399 → $392
2025-03-21
Maintains
Buy
Reason
RBC Capital lowered the firm's price target on Accenture to $392 from $399 and keeps an Outperform rating on the shares. The company delivered solid Q2 numbers, but the shares are reacting negatively to management commentary emphasizing a lack of visibility from DOGE-driven contract reviews of federal work as well as a broader concern of uncertainty from clients, which may stunt spending decisions, particularly on discretionary work, the analyst tells investors in a research note. Demand environment has not bottomed and will continue to weigh on Accenture's growth outlook, RBC added.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Accenture PLC (ACN.N) is 22.64, compared to its 5-year average forward P/E of 27.55. For a more detailed relative valuation and DCF analysis to assess Accenture PLC 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
27.55
Current PE
22.64
Overvalued PE
30.91
Undervalued PE
24.20
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
16.25
Current EV/EBITDA
13.86
Overvalued EV/EBITDA
17.94
Undervalued EV/EBITDA
14.56
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
3.10
Current PS
2.62
Overvalued PS
3.46
Undervalued PS
2.75
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased1712.5%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
ACN News & Events
Events Timeline
(ET)
2025-04-23
05:13:37
Accenture acquires TalentSprint from NSE Academy, terms undisclosed
2025-04-22 (ET)
2025-04-22
15:49:33
Consulting firms propose up to $20B in savings to federal contracts, WSJ says
2025-04-14 (ET)
2025-04-14
05:11:46
Accenture invests in Accenture Ventures, terms undisclosed
Sign Up For More Events
Sign Up For More Events
News
Preview
6.0
04-24ReutersIBM says 15 contracts impacted by DOGE cost cuts, shares drop
Preview
6.0
04-24Investing.comIBM says 15 contracts impacted by DOGE cost cuts, shares drop By Reuters
Preview
8.0
04-23TipRanksACN, BAH – Consulting Firms Propose $20B in Federal Cuts to Please DOGE
Sign Up For More News
People Also Watch
FAQ
What is Accenture PLC (ACN) stock price today?
What is Accenture PLC (ACN)'s business?
What is the price predicton of ACN Stock?
What is Accenture PLC (ACN)'s revenue for the last quarter?
What is Accenture PLC (ACN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Accenture PLC (ACN)'s fundamentals?
How many employees does Accenture PLC (ACN). have?